The Italian version of the Hand Mobility in Scleroderma (HAMIS) test: Evidence for its validity and reliability

Clinical and Experimental Rheumatology

Volumn 28, Issue 5 SUPPL. 62, 2010, Pages

  Del Rosso, A ^a   Bongi, S Maddali ^a   Sigismondi, F ^b   Miniati, I ^a   Bandinelli, F ^a   Matucci Cerinic, M ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b AMuRR Associazione Multidisciplinare Riabilitazione Reumatologica   (Italy)

Author keywords

Disability; HAMIS; Hand; Health assessment questionnaire; Quality of life; Systemic sclerosis

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COCHIN HAND FUNCTION SCALE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION COEFFICIENT; CRONBACH ALPHA COEFFICIENT; EXTERNAL CONSISTENCY; FEMALE; FUNCTION TEST; HAND FUNCTION; HAND MOBILITY IN SCLERODERMA TEST; HAND MOVEMENT; HUMAN; INTERNAL CONSISTENCY; ITALY; MALE; PRIORITY JOURNAL; RANGE OF MOTION; RATING SCALE; RELIABILITY; TEST RETEST RELIABILITY; VALIDITY;

ACTIVITIES OF DAILY LIVING; CROSS-CULTURAL COMPARISON; DISABILITY EVALUATION; FEMALE; HAND; HEALTH STATUS; HUMANS; ITALY; MALE; MIDDLE AGED; MOVEMENT; PSYCHOMOTOR PERFORMANCE; QUESTIONNAIRES; RANGE OF MOTION, ARTICULAR; REPRODUCIBILITY OF RESULTS; SCLERODERMA, SYSTEMIC;

EID: 78650532582     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. CLEMENTS PJ, MEDSGER TA Jr: Cutaneous involvement in systemic sclerosis. In: CLEMENTS PJ, FURST DE (Eds.) Systemic sclerosis. 2nd ed. New York: Lippincott Williams & Wilkins, 2004, p. 129-50.
2. GENERINI S, STEINER G, MINIATI I et al.: Anti-hnRNP and other autoantibodies in systemic sclerosis with joint involvement. Rheumatology (Oxford) 2009;48:920-5.
3. MISRA R, DARTON K, JEWKES RF, BLACK CM, MAINI RN: Arthritis in scleroderma. Br J Rheumatol 1995;34:831-7.
4. POPE JE: Musculoskeletal involvement in scleroderma. Rheum Dis Clin North Am 2003;29:391-408.
5. SANDQVIST G, EKLUND M: Validity of HAMIS: a test of hand mobility in scleroderma. Arthritis Care Res 2000;13:382-7.
6. POOLE JL, STEEN VD: The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res 1991;4:27-31.
7. LAWRENCE E, POPE J, ALZAHRALY Z, LALANI S, BARON M: The relationship between changes in self-reported disability (measured by the Health Assessment Questionnaire - HAQ) in scleroderma and improvement of disease status in clinical practice. Clin Exp Rheumatol 2009;27(Suppl. 54):32-7.
8. STEEN VD, MEDSGER TA: The value of the health assessment questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997;40:1984-91.
9. BROWER LM, POOLE JL: Reliability and validity of the Duruoz Hand Index in persons with systemic sclerosis (scleroderma). Arthritis Rheum 2004;51:805-9.
10. SANDQVIST G, EKLUND M: Hand Mobility in Scleroderma (HAMIS) test: the reliability of a novel hand function test. Arthritis Care Res 2000;13:369-74.
11. SANDQVISTG, EKLUND M: Validity of HAMIS: a test of hand mobility in scleroderma. Arthritis Care Res 2000;13:382-7.
12. MADDALI-BONGI S, DEL ROSSO A, GALLUCCIO F et al.: Efficacy of connective tissue massage and Mc Mennell joint manipulation in the rehabilitative treatment of the hands in systemic sclerosis. Clin Rheumatol 2009;28:1167-73.
13. DURUÖZ MT, POIRAUDEAU S, FERMANIAN J et al.: Development and validation of a rheumatoid Duruöz's Hand Index that assesses functional handicap. J Rheumatol 1996. 23:1167-1172.
14. POIRAUDEAU S, CHEVALIER X, CONROZIER T et al.: Reliability, validity, and sensitivity to change of the Cochin Duruöz's Hand Index in hand osteoarthritis. Osteoarthritis Cartilage 2001. 9:570-577.
15. RANNOU F, POIRAUDEAU S, BEREZNE A et al.: Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), systemic sclerosis HAQ, and medical outcomes study 36-item short form health survey. Arthritis Rheum 2007;57:94-102.
16. LEROY EC, BLACK CM, FLEISCHMAJER R et al.: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
17. SUBCOMMITTEE FOR SCLERODERMA CRITERIA OF THE AMERICAN RHEUMATISM ASSOCIATION DIAGNOSTIC AND THERAPEUTIC CRITERIA COMMITTEE: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
18. BOMBARDIERI S, MEDSGER TA JR, SILMAN AJ, VALENTINI G: The assessment of the patient with systemic sclerosis. Clin Exp Rheumatol 2003;21(Suppl. 29):S2-4.
19. CLEMENTS P, LACHENBRUCH P, SEIBOLD J et al.: Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281-5.
20. INGEGNOLI F, GALBIATI V, BORACCHI P et al.: Reliability and validity of the Italian version of the hand functional disability scale in patients with systemic sclerosis. Clin Rheumatol 2008;27:743-9.
21. DEL ROSSO A, BOLDRINI M, D'AGOSTINO D, PLACIDI GP, SCARPATO A, PIGNONE A: Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers. Arthritis Rheum 2004;51:475-81.
22. LA MONTAGNA G, CUOMO G, CHIAROLANZA I, RUOCCO L, VALENTINI G: HAQ-DI Italian version in systemic sclerosis. Reumatismo 2006;58:112-5.
23. LASSERE MN: A users guide to measurement in medicine. Osteoarthritis Cartilage 2006; (Suppl. A):A10-3.
24. CASALE R, BUONOCORE M, MATUCCI-CERINIC M: Systemic sclerosis (scleroderma): an integrated challenge in rehabilitation. Arch Phys Med Rehabil 1997;78:767-73.
25. VALENTINI G: The assessment of the patient with systemic sclerosis. Autoimmun Rev 2003;2:370-6.
26. KHANNA D, DISTLER O, AVOUAC J et al.: Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS). J Rheumatol 2009;36:2356-61.
27. MADDALI BONGI S, DEL ROSSO A, GALLUCCIO F et al.: Efficacy of a tailored rehabilitation program for systemic sclerosis. Clin Exp Rheumatol 2009;27(Suppl. 54):44-50.